Navigation Links
Section in Biological Technology

Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)

WALTHAM, Mass., Dec. 26 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Alternext US: ILI) announced today, that on December 23, 2008 the Company received notice from the NYSE Alternext US LLC (the "the Exchange") indicating that the Company is not in compliance with certain conditions ...

China-Biotics, Inc. Retains KPMG for the Implementation of Sarbanes-Oxley Act Section 404

SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that it h...

The role of IT in Sarbanes-Oxley Section 404

If you have been following the news recently, you have probably heard about the collapse of Refco, the commodities trading firm that filed for bankruptcy after being accused of allegedly hiding a $430 million bad debt from its shareholders. Refco's CEO has been arrested, and while his innocen...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

... that, because the Reporting Persons have failed to comply with Article II, section 12 of the Company's By-Laws (requiring a stockholder seeking to act by writ...ons deliver to the Company a written notice, in compliance with Article II, section 12 of the Company's By-Laws, requesting the Board to fix a record date for ...

NeurogesX Reports Second Quarter 2009 Results

... To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com . A replay of the conference call will be available beginning August 7, 2009 at 12...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

...fully discussed, as are other factors, in AutoImmune's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission in the section entitled "Risk Factors." We have no plans, and disclaim any obligation, to update or revise any forward-looking statements whether as a result of new...

Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009

...t 11, 2009. Participants are invited to attend the call by visiting www.mficcorp.com and clicking on the webcast link in the Investors, Events section or by dialing 866-314-4483 (within the United States) or 617-213-8049 (outside the United States). The passcode for participants is 61872202. ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...ine, please visit www.intermune.com. Forward-Looking Statements This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this r...

OncoGenex Reports Second Quarter 2009 Financial Results

... and discuss the first quarter results. A live webcast will be available through the Events and Presentations Web page found in the Investor Relations section of the OncoGenex Web site at www.ir.oncogenex.com . Alternatively, you may access the live conference call by dialing 877-548-7912 (U.S. Canada) or...

Telik Announces Second Quarter 2009 Financial Results

...nts in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its annual report on Form 10-K for the year ended December 31, 2008 and subsequent quarterly reports on Form 10-Q. Telik d...

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

... web cast and can be accessed from the company's website at www.PharmAthene.com . A link to the web cast may be found under the Investor Relations section of the website. The web cast will be available for 30 days, or until approximately September 12, 2009. About PharmAthene, Inc. PharmAthen...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...e webcast will be available to all interested parties through the Investors section of Angiotech's website: www.angiotech.com ANGIOTE...iscussion of the risks associated with our business, see the "Risk Factors" section in our annual report for the year ended December 31, 2008 filed with the SE...

Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results

...l 877-440-5796 (domestic) or 719-325-4847 (international). The live webcast and replay access of the teleconference will be available on the Investors section of the Company's website at http://www.ilgenetics.com . About Interleukin Genetics Interleukin Genetics, Inc. develops and markets g...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

...looking statements which are made pursuant to the safe harbor provisions of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

... To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com . A replay of the conference call will be available beginning August 7, 2009 at 12...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...udio webcast can also be accessed via the investor section of the Amicus Therapeutics Web site at www.amicu...cast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days. ...aution is made under the safe harbor provisions of section 21E of the Private Securities Litigation Reform Ac...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

...revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of section 21E of the Private Securities Litigation Reform Act of 1995. Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc. ...

ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12

...l may do so by dialing (866) 305-6438 for domestic callers, or (706) 679-7161 for international callers, or from the webcast on the investor relations section of the Company's Web site at www.adventrx.com . A 48-hour telephone replay will be available approximately one hour after the conclusion o...

Pharmasset to Present at Canaccord Adams Conference

...ternet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at ...e presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at ...ntained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal y...

Advanced Life Sciences to Host 2009 Second Quarter Financial Results Conference Call and Webcast

...m.com/cgi-bin/prnh/20080218/ALSLOGO ) The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing...

Pharmacyclics, Inc. Rights Offering Oversubscribed

...ade in reliance upon the safe harbor provisions of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as ame...ay affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Co...

NxStage Reports Second Quarter 2009 Financial Results

...ll will also be webcast LIVE and can be accessed via the investor relations section of the Company's website at www.nxstage.com/ir.cfm . A replay of ...e archive of the conference call can be accessed via the investor relations section of the Company's website at www.nxstage.com/ir.cfm . About NxSta...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...ial 888-515-2880 from the U.S. or 719-457-2652 for international callers. The Webcast can be accessed on the "Events" page of the "News & Events" section of the Company's Web site at http://www.poniard.com . A replay of the Webcast will be available on the Company's Web site for 10 days. ...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

.... The replay passcode is 22377396. To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's web site at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the call to allow f...

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009

...ebcast can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com , or you may use the li...he archived webcast will be available for 90 days in the Investor Relations section of the BioSpecifics' website at http://www.biospecifics.com . ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...ick access to the conference. To access the live Internet broadcast or a subsequent archived recording, please log onto the Investor Relations section of Senomyx's website at http://investor.senomyx.com . The archived webcast will be available for 30 days following the presentation. Please con...

Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11

...o the Web at the address above The corresponding presentation slides are available for download in the investor relations section of QIAGEN's Web site at www.qiagen.com/goto/ConferenceCall. Contact: Andreas Marathovouniotis, Russo Partners, (212) 845-4235 ...

Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures

...SEC") and applicable Canadian regulatory authorities. For a more thorough discussion of the risks associated with our business, see the "Risk Factors" section in our annual report for the year ended December 31, 2008 filed with the SEC on Form 10-K, and our quarterly report for the three months ended March 3...

ETC Biomedical Announces Chamber Sale in India

...s forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as ame...or the fiscal year ended February 27, 2009, in the section entitled "Risks Particular to Our Business." Share...

Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate

...an historical facts, are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Exchange Act of 1934 and as that term is defined in t...

Human Genome Sciences Announces Closing of Public Offering

...This announcement contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking...

Hoya Announces First Quarter Financial Results for FY2010

... yen in the same period previous year.) The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at: http://www.hoya.co.jp/english/ *Results are preliminary and unaudited. *The yen amounts shown therein are rounded down to the near...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...e conference call will be simultaneously web cast on the Investor Relations section of the Transcept website at www.transcept.com. A replay of the call will be...These and other risks are described in greater detail in the "Risk Factors" section of Transcept periodic reports filed with the SEC. Forward-looking statement...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...st 3, 2009 to discuss the Restanza CAP NDA. The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing...

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

...9 at 1:45 p.m. Eastern time. The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com . This Webcast will be available for replay until August 31, 2009. About Nektar Nektar Th...

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

...ess release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com . The web broadcast of the conference call will be available for replay through Wednesday, August 19...

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

... To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com . A replay of the conference call will be available beginning August 7, 2009 at 12:...

Insmed to Host Second Quarter 2009 Conference Call

...w.insmed.com . Forward-Looking Statements This release contains forward-looking statements which are made pursuant to provisions of section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned cli...

CuraGen Reports Second Quarter 2009 Financial Results

...ents and proprietary rights; and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred in the section entitled "Risk Factors" in CuraGen's Annual Report on Form 10-K for the year ended December 31, 2008 and subsequent Quarterly Reports on Form 10-Q , i...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

...s shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended. Raptor and TorreyPine...use results to differ are described in greater detail in the "Risk Factors" section of TorreyPines' annual report on Form 10-K for the year ended December 31, ...
Other Tags
(Date:7/10/2014)... The Marshall Institute for Interdisciplinary Research (MIIR) ... of Medicine today announced they will be partnering ... anti-cancer drugs. , Under the agreement with Shanghai-based ... share the costs and risks of discovery and ... jointly own any intellectual property and commercialization rights ...
(Date:7/10/2014)... controversy centres around a family of enzymes known as ... group in their active site. At the centre of ... becomes oxidised (ferryl) when a reacting heme is in ... has remained unanswered for decades is whether this oxidation ... group (OH). Resolving this fundamental question has implications for ...
(Date:7/10/2014)... GOES-West satellite spotted smoke over the U.S. Mid-West ... Territories. , At 1200 UTC (8 a.m. EDT) ... of the brownish-colored haze created by forest fires ... way into South Dakota. This image was created ... Space Flight Center, Greenbelt, Md. , According ...
Breaking Biology News(10 mins):Marshall University to partner with international company in drug development venture 2Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3
(Date:7/11/2014)... 2014 Superior Labs announce the launch ... supplements to aid in maintaining optimal digestive health by ... metabolism of fat. Formulated and manufactured in the U.S ... is available in all-natural, vegetarian capsules, with each capsule ... Health Benefits of Artichoke Leaf Extract , Superior Labs ...
(Date:7/11/2014)... TN (PRWEB) July 11, 2014 This morning(July ... Fox 13--Good Morning Memphis to discuss the illegal immigration crisis ... border town of McAllen, Texas. , Dr. Flinn told Good ... it is absolutely wide open… The problem is that they ... influx. Thousands of people per day are coming into the ...
(Date:7/11/2014)... July 11, 2014 Yisrayl Hawkins, Pastor and ... a letter pleading to let the children from other nations, ... allowed to come. Yisrayl says President Barack Obama is fighting ... the United States, and he wants to help him. ... from Guatemala, Honduras and El Salvador being treated as if ...
(Date:7/11/2014)... 2014 Shu Cosmetic Surgery announces ... each qualifying patient undergoing a laser vaginal ... laser vaginal rejuvenation, an advanced type of vaginal ... procedure decreases the internal and external diameters of ... strength, and control, resulting in enhanced sexual gratification ...
(Date:7/11/2014)... TX (PRWEB) July 11, 2014 Based ... urgent care to residents of Brazoria County and surrounding ... that the clinic is now accessible from Northbound Highway ... as a center where patients can get low-cost urgent ... are far from rare, finding places that can match ...
Breaking Medicine News(10 mins):Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Senate Candidate, George Flinn on Fox13 NEWS About the Border Crisis 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 3Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2
Other Contents